1. Home
  2. ANIP vs FINV Comparison

ANIP vs FINV Comparison

Compare ANIP & FINV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • FINV
  • Stock Information
  • Founded
  • ANIP 2001
  • FINV 2007
  • Country
  • ANIP United States
  • FINV China
  • Employees
  • ANIP N/A
  • FINV N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • FINV Finance: Consumer Services
  • Sector
  • ANIP Health Care
  • FINV Finance
  • Exchange
  • ANIP Nasdaq
  • FINV Nasdaq
  • Market Cap
  • ANIP 2.0B
  • FINV 1.9B
  • IPO Year
  • ANIP N/A
  • FINV N/A
  • Fundamental
  • Price
  • ANIP $84.04
  • FINV $5.98
  • Analyst Decision
  • ANIP Strong Buy
  • FINV Strong Buy
  • Analyst Count
  • ANIP 7
  • FINV 2
  • Target Price
  • ANIP $99.29
  • FINV $11.55
  • AVG Volume (30 Days)
  • ANIP 413.5K
  • FINV 1.6M
  • Earning Date
  • ANIP 11-07-2025
  • FINV 11-19-2025
  • Dividend Yield
  • ANIP N/A
  • FINV 4.76%
  • EPS Growth
  • ANIP N/A
  • FINV 32.63
  • EPS
  • ANIP 1.67
  • FINV 1.49
  • Revenue
  • ANIP $826,880,000.00
  • FINV $1,927,901,951.00
  • Revenue This Year
  • ANIP $40.23
  • FINV $11.56
  • Revenue Next Year
  • ANIP $9.65
  • FINV $8.06
  • P/E Ratio
  • ANIP $50.17
  • FINV $4.02
  • Revenue Growth
  • ANIP 48.87
  • FINV 7.84
  • 52 Week Low
  • ANIP $52.50
  • FINV $5.48
  • 52 Week High
  • ANIP $99.50
  • FINV $11.08
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 29.50
  • FINV 38.69
  • Support Level
  • ANIP $79.39
  • FINV $5.95
  • Resistance Level
  • ANIP $95.45
  • FINV $6.34
  • Average True Range (ATR)
  • ANIP 4.46
  • FINV 0.28
  • MACD
  • ANIP -0.97
  • FINV 0.05
  • Stochastic Oscillator
  • ANIP 29.48
  • FINV 48.53

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

Share on Social Networks: